MidCap Financial Investment Corporation 8.00% Notes due 2028 offer institutional investors a compelling fixed-income instrument within the healthcare finance sector, showcasing a noteworthy yield of 8.00%. The company targets middle-market healthcare organizations, delivering tailored financial solutions that not only foster growth but also enhance sustainability in a dynamic environment. With a diversified investment portfolio and a seasoned management team proficient in navigating the healthcare landscape, MidCap Financial is strategically positioned to capitalize on emerging opportunities while effectively managing associated risks, making these notes an attractive addition for those seeking stable returns.
| Revenue (TTM) | $271.69M |
| Gross Profit (TTM) | $271.69M |
| EBITDA | — |
| Operating Margin | 79.50% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $4.14 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 85.90% |
| Quarterly Revenue Growth (YoY) | 15.80% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding